Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Audrey Broussy"'
Autor:
Sophie Gaboyard-Niay, Cécile Travo, Aurélie Saleur, Audrey Broussy, Aurore Brugeaud, Christian Chabbert
Publikováno v:
Disease Models & Mechanisms, Vol 9, Iss 10, Pp 1181-1192 (2016)
Damage to inner ear afferent terminals is believed to result in many auditory and vestibular dysfunctions. The sequence of afferent injuries and repair, as well as their correlation with vertigo symptoms, remains poorly documented. In particular, inf
Externí odkaz:
https://doaj.org/article/fff1f557395e438c9e6a062b97b491a6
Autor:
Audrey Broussy, Christophe Tran Van Ba, Jonas Dyhrfjeld-Johnsen, Sonia Poli, Charlotte Romanet, Mathieu Petremann
Publikováno v:
Otology & Neurotology. 40:254-263
HYPOTHESIS SENS-401 (R-azasetron besylate) is effective against severe acoustic trauma-induced hearing loss. BACKGROUND SENS-401 has calcineurin inhibiting properties and attenuates cisplatin-induced hearing loss in a rat model. Cisplatin-induced and
Autor:
Audrey Broussy, Mathieu Petremann, Christophe Tran Van Ba, Jonas Dyhrfjeld-Johnsen, Charlotte Romanet
Publikováno v:
Otology & Neurotology. 38:1355-1361
HYPOTHESIS SENS-401, an oral clinical-stage drug, may reduce cisplatin-induced hearing loss and cochlear damage in an in vivo model. BACKGROUND Cisplatin is commonly associated with hearing loss, causing significant learning and behavioral difficulti
Autor:
Kourosh Parham, Charlotte Romanet, Jonas Dyhrfjeld-Johnsen, Christophe Tran Van Ba, Maheep Sohal, Audrey Broussy, Mathieu Petremann
Publikováno v:
Hearing research. 371
Biomarkers in easy-to-access body fluid compartments, such as blood, are commonly used to assess health of various organ systems in clinical medicine. At present, no such biomarkers are available to inform on the health of the inner ear. Previously,
Autor:
Jonas Dyhrfjeld-Johnsen, Sophie Gaboyard-Niay, Christian Chabbert, Audrey Broussy, Aurélie Saleur, Aurore Brugeaud
Publikováno v:
Journal of vestibular research : equilibriumorientation. 23(3)
Vestibular neuritis is a neuroinflammatory, peripheral vestibular pathology leading to chronic deficits and long-term disability. While current corticosteroid-based therapy does not appear to positively influence the long term outcome for the patient